Virus-based gene therapy research
Open access
Peer reviewed
Scollr summary
What this paper is about
Developments support further exploration of OVs within biomarker-informed multimodal therapy for select patients of HNSCC, including that OVs selectively infect tumor cells, induce tumor cell lysis and immunogenic cell death, and modulate the tumor microenvironment.
Full abstract
Read the full abstract
Head and neck squamous cell carcinoma (HNSCC) remains difficult to treat, particularly in patients with HPV-negative disease. These patients often get diagnosed too late, their cancer doesn’t respond well to treatment, and they don’t live as long. Oncolytic viruses (OVs) can be used for treating cancer instead of using other cytotoxic methods since they can kill malignant cells directly and cause both local and systemic anti-cancer immune responses. In this review, we focus on current evidence of oncolytic virotherapy (OVT) in HNSCC, including that OVs selectively infect tumor cells, induce tumor cell lysis and immunogenic cell death, and modulate the tumor microenvironment. We also compare some OV platforms which were studied in HNSCC or similar solid-tumor settings: Herpes simplex virus (HSV), adenovirus, vaccinia virus, reovirus, measles virus, vesicular stomatitis virus, and Newcastle disease virus. Finally, we discuss emerging strategies to improve the efficacy and clinical translation of OVT for HNSCC, including tumor- or stimulus-responsive promoters, engineering of viral tropism and receptor specificity, modulation of both antiviral and immunosuppressive pathways, and incorporation between therapeutic payloads and advanced delivery systems. Altogether these developments support further exploration of OVs within biomarker-informed multimodal therapy for select patients of HNSCC.
Direct answer
What can I do from this paper page?
Use this page to scan "Oncolytic viruses in head and neck cancer: therapeutic promise and translational challenges" quickly: start with the summary and abstract, then check the authors, source, topics, and related papers. From here, open Scollr to follow Virus-based gene therapy research, save the paper, or map adjacent work.
Research areas
Follow related topics
Citation
BibTeX
@article{Wang2026Oncolytic,
title = {Oncolytic viruses in head and neck cancer: therapeutic promise and translational challenges},
author = {Haiting Wang and Hui Shen and Mingjun Zhang and Yakui Mou and Chao Ren and Yu Sun and Wanchen Liu and Caiyu Sun and Dongxian Li and Yumei Li and Peng Qu and Xicheng Song},
journal = {Frontiers in Immunology},
year = {2026},
doi = {10.3389/fimmu.2026.1889008},
url = {https://doi.org/10.3389/fimmu.2026.1889008}
}FAQ
Using this paper in a discovery workflow
How do I find related work for this paper?
Use the related papers and topic links on this page as starting points. In Scollr, you can also open the paper and build a literature map around its references, citing papers, and related work.
How can I keep up with new Virus-based gene therapy research papers?
Follow Virus-based gene therapy research in Scollr. New papers from the topic flow into a personalized feed, and you can save useful studies to revisit later.
Can I cite this paper from this page?
This page includes a static BibTeX block for Oncolytic viruses in head and neck cancer: therapeutic promise and translational challenges. Always verify the DOI, source, and publication details against the publisher record before submitting a manuscript.
Follow this research in Scollr
Follow the topics and authors behind this paper, save useful studies, and build a literature map when you are ready to go deeper.
Get the app